BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 17551254)

  • 1. Reliable identification of small cell lung cancer in cytological specimens by immunocytology.
    Metzgeroth G; Mantz C; Kuhn C; Schultheis B; Hehlmann R; Hastka J
    Onkologie; 2007 Jun; 30(6):311-5. PubMed ID: 17551254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P16 is a useful supplemental diagnostic marker of pulmonary small cell carcinoma in small biopsies and cytology specimens.
    Švajdler M; Mezencev R; Ondič O; Šašková B; Mukenšnábl P; Michal M
    Ann Diagn Pathol; 2018 Apr; 33():23-29. PubMed ID: 29566943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic accuracy of cytology and immunocytology in carcinomatous effusions.
    Metzgeroth G; Kuhn C; Schultheis B; Hehlmann R; Hastka J
    Cytopathology; 2008 Aug; 19(4):205-11. PubMed ID: 17573908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Significance of MOC-31 and CD56 detection in human lung carcinoma tissues].
    Huang YG; Xu YY; Zheng ZH
    Ai Zheng; 2002 Nov; 21(11):1235-7. PubMed ID: 12526223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunocytochemical detection of human lung cancer heterogeneity using antibodies to epithelial, neuronal, and neuroendocrine antigens.
    Broers JL; Rot MK; Oostendorp T; Huysmans A; Wagenaar SS; Wiersma-van Tilburg AJ; Vooijs GP; Ramaekers FC
    Cancer Res; 1987 Jun; 47(12):3225-34. PubMed ID: 2438035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of p63 as an effective immunomarker in the diagnosis of pulmonary squamous cell carcinomas on de-stained bronchial lavage cytological smears.
    Uke M; Rekhi B; Ajit D; Jambhekar NA
    Cytopathology; 2010 Feb; 21(1):56-63. PubMed ID: 19744186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunocytologic diagnosis of small-cell lung cancer in imprint smears.
    Tome Y; Hirohashi S; Noguchi M; Matsuno Y; Kishi K; Uei Y; Shimosato Y
    Acta Cytol; 1991; 35(5):485-90. PubMed ID: 1656682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of epithelial- and neural type of intermediate filament proteins in human lung tumors.
    Ramaekers F; Broers J; Rot MK; Oostendorp T; Wagenaar S; Vooijs P
    Acta Histochem Suppl; 1987; 34():45-56. PubMed ID: 3033739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of cytology in small cell lung carcinoma diagnostic--single-center study.
    Milicić V; Prvulović I; Misić M; Perić M; Samardzić S; Tomić K
    Coll Antropol; 2014 Jun; 38(2):611-6. PubMed ID: 25144997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitation of Ki-67 expression in the differential diagnosis of reserve cell hyperplasia vs. small cell lung carcinoma.
    Grefte JM; Salet-van de Pol MR; Gemmink JH; Bulten J; Hanselaar AG; de Wilde PC
    Acta Cytol; 2004; 48(5):608-12. PubMed ID: 15471251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synchronous primary lung cancer presenting with small cell carcinoma and non-small cell carcinoma: diagnosis and treatment.
    Hiraki A; Ueoka H; Yoshino T; Chikamori K; Onishi K; Kiura K; Bessho A; Mimoto J; Date H; Ando A; Shimizu N; Harada M
    Oncol Rep; 1999; 6(1):75-80. PubMed ID: 9864405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laminin and type VII collagen distribution in different types of human lung carcinoma: correlation with expression of keratins 14, 16, 17 and 18.
    Wetzels RH; Schaafsma HE; Leigh IM; Lane EB; Troyanovsky SM; Wagenaar SS; Vooijs GP; Ramaekers FC
    Histopathology; 1992 Apr; 20(4):295-303. PubMed ID: 1374358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant pleural effusions due to small-cell lung carcinoma: a cytologic and immunocytochemical study.
    Chhieng DC; Ko EC; Yee HT; Shultz JJ; Dorvault CC; Eltoum IA
    Diagn Cytopathol; 2001 Dec; 25(6):356-60. PubMed ID: 11747231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic application of a monoclonal antibody against small cell lung cancer.
    Postmus PE; Hirschler-Schulte TJ; De Leij L; Poppema S; Elema JE; Edens ET; Mesander G; Sluiter HJ; The TH
    Cancer; 1986 Jan; 57(1):60-3. PubMed ID: 3000572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytology applications of p63 and TTF-1 immunostaining in differential diagnosis of lung cancers.
    Wu M; Szporn AH; Zhang D; Wasserman P; Gan L; Miller L; Burstein DE
    Diagn Cytopathol; 2005 Oct; 33(4):223-7. PubMed ID: 16138374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of serum tumor markers in patients with lung cancer.
    Hatzakis KD; Froudarakis ME; Bouros D; Tzanakis N; Karkavitsas N; Siafakas NM
    Respiration; 2002; 69(1):25-9. PubMed ID: 11844959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies in lung cancer pathology.
    Broers JL; Klein Rot M; de Leij L; Wagenaar SS; Carney DN; Vooijs GP; Ramaekers FC
    Eur J Respir Dis Suppl; 1987; 149():11-8. PubMed ID: 2438150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroendocrine and epithelial markers in diagnostic bronchial lung cancer biopsy specimens.
    Burnett HE; Zakhour HD; Walker C
    Eur J Cancer; 1992; 28A(4-5):853-5. PubMed ID: 1381930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of the quantitative Ki-67 proliferation index and CD56 together in the cytologic diagnosis of small cell lung carcinoma and other lung neuroendocrine tumors.
    Zheng G; Ettinger DS; Maleki Z
    Acta Cytol; 2013; 57(3):281-90. PubMed ID: 23635388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Application of protein markers in combination with ThinPrep bronchial brush cytology in classification of lung cancer subtypes].
    Yang Y; Pan QJ; Teng MF; Li ZL; Zhao LL; Han NJ; Gao YN; Cao J
    Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):616-9. PubMed ID: 19102942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.